Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
News headlines Recursion Pharmaceuticals (RXRX) reported mixed Q2 2026 results, showing significant advancements in drug development despite a drop in revenue. The company has achieved key milestones, ...
At close: August 14 at 4:00:01 PM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results